jablongo2
Re:A Government Guide to Keeping Insulin Unaffordable
on Sunday July 07, 2019 @10:07PM (#20379389)
The problem is that the generics are equivalent to insulin from the 70's, when complications of type-1 diabetes were considered almost unavoidable. You can be super diligent and figure out how to manage your diet to make it work with the cheaper stuff, but that takes years of practice and conditioning. If you have to switch from something like humalog and an insulin pump, to injections of Regular insulin a two times a day or so, you are gonna be screwed.
Re:A Government Guide to Keeping Insulin Unaffordable
on Sunday July 07, 2019 @10:00PM (#20379357)
There may be some confusion about "delivery mechanism" here. In this context the only relevant definition would be referring to chemical components in updated formulas for the injectable solution. Delivery _devices_ would have no relevance to the patent of the injectable solution.
Re:A Government Guide to Keeping Insulin Unaffordable
on Sunday July 07, 2019 @09:46PM (#20379310)
As a type-1 diabetic and user of Lilly and Novo Nordisk insulins, this article is spot on. People are literally dying in some cases due to this dysfunction.
One thing that is not mentioned is that the dynamics of prescription-writing in the first place is anti-competitive in terms of price. Fiasp and Humalog are equivalent fast acting insulins from Novo-Nordisk and Lilly - competition will only happen when patients can decide which one to take instead of their doctors, who are not sensitive to small price differences (and in most cases are not themselves taking the drug).